Document Detail


Detection of small hepatocellular carcinoma: intraindividual comparison of gadoxetic acid-enhanced MRI at 3.0 and 1.5 T.
MedLine Citation:
PMID:  21467946     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: To investigate the diagnostic efficacy of gadoxetic acid-enhanced magnetic resonance imaging (MRI) at 3.0 T for the detection of hepatocellular carcinomas (HCC) and compare with that at 1.5 T.
MATERIALS: Forty patients with 54 HCCs (size range: 0.6-2.0 cm) underwent gadoxetic acid-enhanced MRIs at both 1.5 and 3.0 T with 3 to 8 days interval. The MRIs were compared quantitatively by measuring tumor-liver contrast-to-noise ratio, and qualitatively by evaluating tumor-liver contrast using matched pairs analysis. Diagnostic accuracy and sensitivity were also evaluated by the consensus readings of 2 reviewers using the alternative-free response receiver operator characteristic (ROC) method.
RESULTS: Although the tumor-liver contrast-to-noise ratio for the arterial phase was significantly higher at 3.0 T than at 1.5 T (30.2 ± 21.4 vs. 35.2 ± 22.9; P = 0.04), we found similar values for the hepatocyte phase (38.2 ± 24.6 vs. 38.4 ± 25.3; P = 0.762). Matched pairs analysis indicated that the relative tumor-liver contrast was better in 7 and 9 lesions in the arterial phase and hepatocyte phase at 3.0 T, respectively, than those at 1.5 T. The diagnostic accuracy and sensitivity of 3.0-T imaging [Az, 0.988; 92.6% (n = 50)] were slightly higher than those of 1.5-T imaging [Az, 0.981; 88.9% (n = 48)], but the difference was not statistically significant (P = 0.487).
CONCLUSIONS: Gadoxetic acid-enhanced MRIs at 1.5 and 3.0 T showed similar diagnostic performances for detecting small HCCs. However, there was a tendency toward increased reader confidence for the arterial phase and hepatocyte phase with 3.0 T compared with 1.5 T.
Authors:
Young Kon Kim; Chong Soo Kim; Young Min Han; Hee Chul Yu; Dongil Choi
Related Documents :
17512326 - Image fusion of fluid-attenuated inversion recovery magnetic resonance imaging sequence...
21136056 - Prospective volumetric assessment of the liver on a personal computer by nonradiologist...
17541726 - Focal macroscopic fat deposition within the right ventricular wall in asymptomatic pati...
8421756 - Characterization of hemorrhagic adnexal lesions with mr imaging: blinded reader study.
19357796 - Advanced magnetic resonance imaging metrics: implications for multiple sclerosis clinic...
7566396 - 192ir induced radiation damage in monkey brain assessed with magnetic resonance imaging...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Investigative radiology     Volume:  46     ISSN:  1536-0210     ISO Abbreviation:  Invest Radiol     Publication Date:  2011 Jun 
Date Detail:
Created Date:  2011-05-09     Completed Date:  2011-08-24     Revised Date:  2011-09-28    
Medline Journal Info:
Nlm Unique ID:  0045377     Medline TA:  Invest Radiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  383-9     Citation Subset:  IM    
Affiliation:
Sungkyunkwan University School of Medicine. Department of Radiology, Samsung Medical Center,Sungkyunkwan University School of Medicine, Seoul, South Korea. jmyr@dreamwiz.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Carcinoma, Hepatocellular / diagnosis*,  radiography
Contrast Media*
Female
Gadolinium DTPA*
Humans
Image Enhancement / methods
Liver Neoplasms / diagnosis*,  radiography
Magnetic Resonance Imaging*
Male
Middle Aged
Sensitivity and Specificity
Chemical
Reg. No./Substance:
0/Contrast Media; 0/gadolinium ethoxybenzyl DTPA; 80529-93-7/Gadolinium DTPA
Comments/Corrections
Erratum In:
Invest Radiol. 2011 Sep;46(9):600

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Noninvasive In Vivo Assessment of Renal Tissue Elasticity During Graded Renal Ischemia Using MR Elas...
Next Document:  In Vivo Detection of Choline in Ovarian Tumors Using 3D Magnetic Resonance Spectroscopy.